Bank of Baroda makes a corporate announcement

Bank of Baroda’s global NIM declined to 2.77% in Q1 FY27, down 12 bps QoQ from 2.89% and 14 bps YoY from 2.91%. Domestic NIM was stronger at 2.93%, indicating that the sequential pressure was partly driven by the higher share of lower-margin international business. ^{[1] [2]}

Margin bridge

• Deposit repricing: Cost of deposits fell 12 bps QoQ to 4.66%, which was a positive contribution to NIM rather than the cause of the decline. ^[3]
• Yield on advances: Reported yield on advances was 7.37% for Q1 FY27, but the filing does not provide a comparable Q4 FY26 yield figure. ^[3]
• Attribution: Therefore, the bank has not disclosed a precise basis-point split between deposit repricing and the change in advance yield. The reported 12 bps NIM decline cannot be mechanically assigned to advance-yield compression from the available disclosure.

Management’s explanation points instead to asset growth running ahead of NII growth, dilution from the lower-margin international book, and pressure from the overall asset mix. It also said that better pricing of non-repo-linked corporate loans and lower incremental bulk-deposit costs should help stabilise margins. ^{[4] [5]}

Analyst read: Deposit-cost repricing provided an approximate 12 bps tailwind, but this was more than offset by asset-mix and balance-sheet-growth effects. The exact contribution from the yield on advances remains unquantified; the evidence supports asset-side and mix pressure, not a conclusion that the full 12 bps decline was caused by advance-yield repricing.

Bank of Baroda’s latest reported quarter, Q1 FY27 ended 30 June 2026, showed a slippage ratio of 0.91% and a PCR of 93.28% including TWO; PCR was 75.07% excluding TWO. Quarterly credit cost was 0.29%. ^[6]

Reconciliation with FY27 guidance

• Slippages are below guidance: management retained a FY27 slippage range of 1.00–1.25%, so the Q1 figure of 0.91% is running below the guided band. ^[7]
• Credit cost has headroom: management’s FY27 guidance is for credit cost of below 0.60%, versus 0.29% in Q1 FY27. ^[8]
• ECL transition risk remains absorbable: management estimated that ECL migration could add 15–20 bps to credit cost. Mechanically adding this to Q1’s 0.29% gives a 0.44–0.49% implied range, still below the 0.60% guidance threshold. This is a derived sensitivity, not management’s full-year forecast. ^[9]
• PCR provides loss-absorption comfort, but is not itself a credit-cost forecast: the high PCR indicates substantial provisioning coverage. However, management also used conservative write-offs in Q1 to protect PCR; this modestly increased reported GNPA/NNPA sequentially, while write-offs themselves were already fully provided. ^[10]

Assessment: the Q1 asset-quality metrics are consistent with the bank’s stated FY27 credit-cost guidance. The main monitorable is whether the estimated ECL-transition charge and any normalization in write-offs keep full-year credit cost below 0.60%; the current 0.29% run rate leaves a meaningful buffer.

Bank of Baroda is below all five peers on total capital adequacy and ahead of only Canara Bank on CET-1. On the latest Q1 FY27 figures, Bank of Baroda reported CRAR of 16.30% and CET-1 of 13.90%, despite reporting 17.4% YoY credit growth. ^[3] The capital position is adequate, but the buffer is thinner than most of its large public-sector peers.

Q1 FY27 capital comparison

The comparison is directionally useful but not perfectly like-for-like because the disclosures do not uniformly state standalone versus consolidated scope. There is also a Bank of Baroda data inconsistency: the structured Q1 table reports consolidated CET-1 of 14.40%, while management’s earnings-call disclosure reports 13.90%; the latter is used above because it is paired with the bank’s reported CRAR of 16.30%. ^{[17] [3]}

Capital allocation strategy

Management’s near-term strategy is to support growth without an immediate common-equity issue:

• Use the existing capital cushion first: management said there was no immediate requirement to raise equity with CRAR at 16.30% and CET-1 at 13.90%. ^[9]
• Add capital through Tier 2 instruments: the bank intends to raise approximately Rs 6,000 Crores of Tier 2 capital in FY27; the capital-raising committee approved up to Rs 6,000 Crores through AT1 and/or Tier 2 bonds, in tranches through March 2027 and beyond. ^{[9] [18]}
• Use market-based funding to support balance-sheet growth: management’s broader resource-mobilisation plan is approximately USD 4-5 billion through FCNR, MTN and other external borrowing routes, with an initial bond-issuance plan of up to USD 1 billion, subject to pricing and market conditions. ^{[19] [20]}
• Maintain a measured growth target: despite the 17.4% Q1 credit-growth rate, management retained FY27 credit-growth guidance of 12-14%, alongside deposit-growth guidance of 10-12%. ^[7]

The important qualification is that this is not a permanent “no equity dilution” policy. Management has also disclosed a plan to raise Rs 8,500 Crores of equity by March 2028, with timing dependent on capital requirements, market conditions and achievable pricing. ^[9] Thus, the stated approach is no immediate dilution, supplemented by retained capital generation and Tier 2/other borrowings in the near term; equity remains a medium-term option if 16-17% growth is sustained. Management also estimates that the ECL transition could reduce CRAR by roughly 110 bps, which makes the timing and mix of future capital raising important. ^[9]